title: [Hemocomponent therapy of central involution chorioretinal dystrophy].
abstract: Hemocomponent therapy was used in 181 patients (347 eyes) with central chorioretinal dystrophy. Activated autoplasma possessing a marked resorptive effect, consisting in resorption of hemorrhages and exudations on the fundus oculi, was used. Vision acuity improved in 75% of examined eyes by an average of 0.2 diopters.
authors.forename: A I
authors.initials: AI
authors.lastname: Mukha
authors.forename: V S
authors.initials: VS
authors.lastname: Lysenko
authors.forename: V V
authors.initials: VV
authors.lastname: Galileeva
authors.forename: L D
authors.initials: LD
authors.lastname: Andreeva
authors.forename: O A
authors.initials: OA
authors.lastname: Markova
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D016913:Blood Component Transfusion; D001804:Blood Transfusion, Autologous; D015862:Choroid Diseases / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000627:therapeutic use; D011817:Rabbits; D012162:Retinal Degeneration / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D014792:Visual Acuity
chemical_list: D010952:Plasma Substitutes
vernacular_title: Gemokomponentnaia terapiia tsentral'noĭ involiutsionnoĭ khorioretinal'noĭ distrofii.